Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis

<h3>Background</h3><p dir="ltr"><u>Chronic obstructive pulmonary disease </u>(COPD) significantly impacts global health due to persistent airflow limitation and inflammation. Despite standard therapies, symptoms persist. Ensifentrine, targeting both <u>b...

Full description

Saved in:

Bibliographic Details
Main Author:	Ambanna Yappalparvi (21260018) (author)
Other Authors:	Ashok Kumar Balaraman (22282333) (author), G. Padmapriya (22282336) (author), Shilpa Gaidhane (745829) (author), Irwanjot Kaur (20767955) (author), Madan Lal (773504) (author), Suhaib Iqbal (20767958) (author), G.V. Siva Prasad (22282339) (author), Atreyi Pramanik (8334333) (author), Teena Vishwakarma (20767964) (author), Praveen Malik (6560504) (author), Promila Sharma (14322356) (author), Ankit Punia (20767967) (author), Megha Jagga (20767970) (author), Doddolla Lingamaiah (22282342) (author), Rachana Mehta (12059853) (author), Sanjit Sah (19709571) (author), Quazi Syed Zahiruddin (13231791) (author), Hashem Abu Serhan (16003271) (author), Muhammed Shabil (16677981) (author), Ganesh Bushi (19709574) (author)
Published:	2024
Subjects:	Biomedical and clinical sciences Clinical sciences Pharmacology and pharmaceutical sciences Health sciences Epidemiology Ensifentrine COPD PDE3 inhibitor PDE4 inhibitor Dyspnea FEV1 Quality of life Adverse events
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis

Similar Items